Robert Lechleider - 21 Nov 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Medical Officer
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
21 Nov 2024
Net transactions value
+$149,800
Form type
4
Filing time
25 Nov 2024, 08:35:28 UTC
Previous filing
13 Aug 2024
Next filing
31 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $149,800 +15,805 $9.48 15,805 21 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price for the reported transactions was $9.478. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, the Reporting Person will provide the full information regarding the securities purchased.